Siglecs as Immune Cell Checkpoints in Disease.

Area of Science:

• Immunology
• Glycobiology

Background:

• Sialic acid-binding immunoglobulin-type lectins (Siglecs) are key immune cell surface receptors.
• They recognize sialic acid-containing glycans, mediating self/nonself discrimination.
• Siglecs are expressed on various white blood cells, influencing immune responses.

Purpose of the Study:

• To review the Siglec family and their functions in immune cell signaling.
• To explore the roles of Siglecs in various human diseases.
• To discuss therapeutic strategies targeting Siglecs.

Main Methods:

• Literature review of Siglec research.
• Analysis of Siglec expression patterns.
• Examination of Siglec involvement in disease pathogenesis.

Main Results:

• Siglecs play critical roles in regulating immune cell signaling pathways.
• Dysregulated Siglec function is implicated in cancer, asthma, allergy, neurodegeneration, and autoimmune diseases.
• Siglecs serve as important checkpoints in immune cell responses.

Conclusions:

• The Siglec family represents a promising target for therapeutic interventions.
• Targeting Siglecs may offer novel treatment strategies for a range of human diseases.
• Further research into Siglec biology is crucial for developing effective therapies.